Literature DB >> 6779335

Drug preference and mood in humans: d-amphetamine.

C E Johanson, E H Uhlenhuth.   

Abstract

A total of 31 normal human volunteers participated in a nine-session experiment. During the first four sessions, they received alternately 5 mg d-amphetamine or placebo. During the next five sessions, they were given a choice between amphetamine and placebo. Subjective effects were assessed using the Profile of Mood States (POMS) before the drug was taken and 1, 3, and 6 h later. Subjects chose amphetamine a mean of 4.03 times. Compared with placebo, amphetamine produced changes in mood on the POMS including increased Vigor, Elation, Friendliness, Arousal and Positive Mood and decreased Confusion. These differences were greatest 3 hr after ingestion. Mood changes produced by d-amphetamine were comparable in all subjects regardless of the actual number of times each chose the drug. These data suggest that that subjective effects do not predict drug choice. The results are discussed in terms of developing methods for predicting the abuse potential of psychotropic drugs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6779335     DOI: 10.1007/BF00433062

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Nicotine self-administration in rats.

Authors:  H M Hanson; C A Ivester; B R Morton
Journal:  NIDA Res Monogr       Date:  1979-01

2.  A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts.

Authors:  W R MARTIN; H F FRASER
Journal:  J Pharmacol Exp Ther       Date:  1961-09       Impact factor: 4.030

3.  A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys.

Authors:  C E Johanson; R L Balster
Journal:  Bull Narc       Date:  1978 Jul-Sep

4.  Assessing the subjective effects of stimulants in casual users. A methodology and preliminary results.

Authors:  J O Cole; H G Pope; R LaBrie; M Ionescu-Pioggia
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

5.  Effects of short- and long-term administration of pentazocine in man.

Authors:  D R Jasinski; W R Martin; R D Hoeldtke
Journal:  Clin Pharmacol Ther       Date:  1970 May-Jun       Impact factor: 6.875

6.  Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone.

Authors:  D R Jasinski; W R Martin; J D Sapira
Journal:  Clin Pharmacol Ther       Date:  1968 Mar-Apr       Impact factor: 6.875

Review 7.  Self administration of and behavioral dependence on drugs.

Authors:  C R Schuster; T Thompson
Journal:  Annu Rev Pharmacol       Date:  1969       Impact factor: 13.820

8.  Self-administration of d-amphetamine by rats.

Authors:  R Pickens; W C Harris
Journal:  Psychopharmacologia       Date:  1968

9.  Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats.

Authors:  J R WEEKS
Journal:  Science       Date:  1962-10-12       Impact factor: 47.728

10.  The reinforcing properties of procaine, chloroprocaine and proparacaine in rhesus monkeys.

Authors:  C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1980-02       Impact factor: 4.530

View more
  55 in total

1.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

2.  Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.

Authors:  Matthew G Kirkpatrick; Nicholas I Goldenson; Nahel Kapadia; Christopher W Kahler; Harriet de Wit; Robert M Swift; John E McGeary; Steve Sussman; Adam M Leventhal
Journal:  Psychopharmacology (Berl)       Date:  2015-10-02       Impact factor: 4.530

3.  Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status.

Authors:  Thomas H Kelly; Glenn Robbins; Catherine A Martin; Mark T Fillmore; Scott D Lane; Nancy G Harrington; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

Review 4.  The role of human drug self-administration procedures in the development of medications.

Authors:  S D Comer; J B Ashworth; R W Foltin; C E Johanson; J P Zacny; S L Walsh
Journal:  Drug Alcohol Depend       Date:  2008-04-24       Impact factor: 4.492

5.  A within-subject assessment of the discriminative stimulus and reinforcing effects of self-administered cocaine in rhesus monkeys.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

6.  Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: a pilot study.

Authors:  Melissa A Miller; Anya Bershad; Andrea C King; Royce Lee; Harriet de Wit
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

7.  Psychopharmacology of theobromine in healthy volunteers.

Authors:  Matthew J Baggott; Emma Childs; Amy B Hart; Eveline de Bruin; Abraham A Palmer; Joy E Wilkinson; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2013-02-19       Impact factor: 4.530

8.  Asians compared to Whites show increased response to d-amphetamine on select subjective and cardiovascular measures.

Authors:  Raina D Pang; Matthew G Kirkpatrick; Nicholas I Goldenson; Casey R Guillot; Adam M Leventhal
Journal:  Pharmacol Biochem Behav       Date:  2016-03-04       Impact factor: 3.533

9.  Effects of oxycodone on brain responses to emotional images.

Authors:  Margaret C Wardle; Daniel A Fitzgerald; Michael Angstadt; Christine A Rabinak; Harriet de Wit; K Luan Phan
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

10.  The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.

Authors:  R De La Garza; J J Mahoney; C Culbertson; S Shoptaw; T F Newton
Journal:  Pharmacol Biochem Behav       Date:  2008-01-22       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.